Nadezhda M Kolyasnikova

9PUBLICATIONS
29CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 27, 2026
From Oncolysis to Adaptive Immunity: Yellow Fever Virus 17D and Ruxolitinib Activate Antitumor Immune Responses in Pancreatic Cancer Models.

|Jan 22, 2026
The immune response after vaccination in recipients against different subtypes of tick-borne encephalitis virus (Flaviviridae: Orthoflavivirus).

E A Orlova, A L Ivanova, V A Mishchenko

|Jan 24, 2025
Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer.

Alina S Nazarenko, Yulia K Biryukova, Kirill N Trachuk

|Jan 22, 2025
[The impact of innate immune response on the efficacy of oncolytic viruses].

K N Trachuk, N B Pestov, Y K Biryukova

|Dec 17, 2024
Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment.

Alina S Nazarenko, Alena O Shkirdova, Ekaterina A Orlova

|Aug 29, 2024
The Specificity of Epizootic and Epidemiological Processes in Natural Foci of Hemorrhagic Fever with Renal Syndrome and Tick-Borne Encephalitis in Russia, as the Basis for the Prospects of Creating a Combined Vaccine for the Prevention of These Infections.

Evgeniy Tkachenko, Alexandra Balkina, Dmitriy Trankvilevsky

Pageof 2

Frequent Collaborators

5 joint publications

Mikhail Vorovich

4 joint publications

Yulia K Biryukova

3 joint publications

Aydar A Ishmukhametov

3 joint publications

Ekaterina A Orlova